HomeAtlasDashboardChartsMetalsResearchPersonsBubble MapGlobeLeadershipLensesMethodologyGlossarySource ↗
Independent research & opinion. Gradings are automated / LLM-assisted and may contain errors or hallucinations; nothing here is a statement of fact, financial advice, or an accusation of wrongdoing by any party. Claims about identifiable people or organizations reflect public records + good-faith interpretation; intent is not inferred from association. Methodology & disclaimer.

J&J talc + the "Texas two-step" — corporate liability-engineering (and the courts that keep rejecting it)

Built 2026-06-24 from research/spec-jj-talc-texas-two-step.json. The connective node for the mass-tort cluster. Companion to spec-opioid-crisis (SCOTUS Purdue), spec-pfas-forever-chemicals (Chemours spinoff), the asbestos/Camp-Lejeune backlog; JNJ is a node.

Frame. J&J faces ~68,000 talc claims and tried three times to escape them via the "Texas two-step": spin the liabilities into a shell subsidiary, then bankrupt only that shell while the $400B+ parent stays solvent. This block adds a Liability_Engineering thesis node linking the same playbook across talc (J&J) ↔ PFAS (DuPont→Chemours) ↔ opioids (Purdue/Sackler releases) and the SCOTUS check. Discipline. Filings, attempts, and offers = fact. The third attempt's outcome is reported divergently — both accounts given below with dates (per the "present conflicting sources" rule). Carcinogenicity is contested-in-science but juries have found for plaintiffs. Dignified victim framing. Overlay; excluded from the proofs.

1. The litigation

~68,029 pending MDL talc suits (June 2026) alleging ovarian cancer + mesothelioma (asbestos-contaminated talc). J&J stopped selling talc-based baby powder globally (2023) (switched to cornstarch); maintains its talc is asbestos-free. Verdicts go both ways — e.g., an $8M Massachusetts mesothelioma verdict (June 2025). Claims/verdicts fact; causation contested-in-science.

2. The Texas two-step

Under Texas's divisive-merger statute, a company splits — all tort liabilities into a new shell, the operating business + assets into another — then puts only the shell into Chapter 11, freezing all litigation and forcing a single bankruptcy settlement while the solvent parent never files. J&J ran it three times:

3. The third attempt — both accounts, with dates

Rather than pick one:

Weight: the dated court record + March-2025 legal reporting (B) is the stronger, more-recent account; (A) appears to describe the pre-dismissal proposed plan / the creditor vote, and in the SEO pages to be stale or erroneous. Both retained so a reader can adjudicate by date. Filings + Mar-2025 dismissal + MDL count fact; "approved/fund-created" unsupported as of the dated record.

4. The settlement offers

Offers escalated: ~$8.9B → ~$10B (nominally ~$13.7B over 25 yr, ~$6.5–8B present value) — all tied to the bankruptcy vehicle the courts rejected, so the money was contingent on a maneuver that (per the dated record) failed. Offer figures fact.

5. The liability-engineering playbook (the thesis this block crystallizes)

Large defendants increasingly try to contain mass-tort liability through corporate/bankruptcy engineering rather than pay in the tort system:

The judicial check is tightening: courts dismissed J&J's three two-steps, and the Supreme Court struck the Purdue releases (Harrington v. Purdue, 2024). The §524(g) asbestos trust system is the legitimate, court-sanctioned template all of this descends from. Playbook + judicial pushback fact; "systematic strategy" is the labeled synthesis.

6. The honest reading

Real claims (68k) + contested-but-jury-credited harm; a solvent parent repeatedly trying to offload liability into a bankrupt shell; and — on the dated record — courts repeatedly refusing. The settlement money was real but contingent on the rejected maneuver. The deeper, cross-cutting finding (the Liability_Engineering node): the same containment playbook recurs across talc, PFAS, and opioids, with the courts/SCOTUS as the binding constraint.

Sources: Bailey Glasser — Texas court dismisses J&J's third bankruptcy (Mar 2025); BioSpace — 16 years, 3 two-steps; Verus — Texas Two-Step explained; J&J 8-K (talc plan); ConsumerNotice — talc lawsuits/settlements.

← Research index · structured data: spec-jj-talc-texas-two-step.json · spec-jj-talc-texas-two-step.md